– Mr. Bazemore joins AIRNA with over 30 years of experience leading clinical- and commercial-stage biotechs with a focus on rare diseases CAMBRIDGE, Mass., June 2, 2026 – AIRNA, a biotech company pioneering RNA-editing therapeutics to transform the lives of patients with rare and common conditions, today announced that Todd Bazemore has been appointed President and […] The post AIRNA Appoints Industry Veteran Todd Bazemore as President and CEO to Drive the Next Stage of Company Growth appeared first on Airna .